BANK OF AMERICA CORP /DE/ - LINEAGE CELL THERAPEUTICS IN ownership

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 117 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$7,557
-92.6%
6,404
-91.1%
0.00%
Q2 2023$101,816
-95.3%
72,210
-95.0%
0.00%
Q1 2023$2,165,669
+179772.8%
1,443,779
+140208.9%
0.00%
Q4 2022$1,204
+20.4%
1,029
+2.2%
0.00%
Q3 2022$1,000
-94.4%
1,007
-90.8%
0.00%
Q2 2022$18,000
+5.9%
11,0000.0%0.00%
Q1 2022$17,000
-80.2%
11,000
-68.8%
0.00%
Q4 2021$86,000
+196.6%
35,243
+204.0%
0.00%
Q3 2021$29,000
-40.8%
11,592
-33.5%
0.00%
Q2 2021$49,000
-25.8%
17,429
-37.8%
0.00%
Q1 2021$66,000
+187.0%
28,021
+116.1%
0.00%
Q4 2020$23,000
+91.7%
12,9640.0%0.00%
Q3 2020$12,000
-91.7%
12,964
-92.2%
0.00%
Q2 2020$145,000
+1015.4%
166,607
+938.8%
0.00%
Q1 2020$13,000
-43.5%
16,039
-37.0%
0.00%
Q4 2019$23,000
-41.0%
25,470
-37.6%
0.00%
Q3 2019$39,00040,8050.00%
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q3 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 34,935,485$41,223,8723.66%
Raffles Associates 1,587,739$1,873,5322.48%
Defender Capital, LLC. 5,184,510$6,117,7222.22%
Prescott General Partners LLC 1,851,851$2,185,1840.14%
DCF Advisers, LLC 82,751$97,6460.05%
Beirne Wealth Consulting Services, LLC 45,000$63,4500.05%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 781,766$922,4840.02%
Fort Sheridan Advisors LLC 83,931$99,0390.02%
MAI Capital Management 954,688$1,126,5320.02%
Piscataqua Savings Bank 12,499$14,6230.01%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders